GlassScriptPhysician profile
Joshua Greenspan
NPI 1962457218
$5,981.01
in general payments reported to CMS, 2019-2025
33 companies · $1,693 in 2025
The $1,693 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,072 · 2020: $588 · 2021: $20.13 · 2022: $27.27 · 2023: $131 · 2024: $449 · 2025: $1,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,410 · Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,410.41 |
| Food and Beverage | $862.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,873.31 | 2024-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Teva Pharmaceuticals USA, INC. | $404.52 | 2019-2020 | |
| Pacira Therapeutics, INC. | $386.16 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $276.90 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $267.31 | 2019-2020 | |
| Lilly USA, LLC | $237.65 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $210.31 | 2019-2020 | |
| Boston Scientific Corporation | $207.74 | 2019-2025 | General - Pain Management |
| Abbott Laboratories | $198.83 | 2020-2024 | Eterna |
| Nevro Corp. | $192.06 | 2019-2020 | |
| Lundbeck LLC | $187.43 | 2023-2024 | Vyepti |
| Daiichi Sankyo INC. | $150.36 | 2019 | |
| Pfizer INC. | $142.97 | 2019 | |
| Assertio Therapeutics, INC. | $142.86 | 2019-2020 | |
| Painteq LLC | $139.34 | 2024 | Painteq |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $112.82 | 2019 | |
| Flowonix Medical Incorporated | $107.46 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $105.79 | 2019 | |
| Depuy Synthes Sales INC. | $86.47 | 2019 | |
| Smith+Nephew, INC. | $84.48 | 2019 | |
| Convatec INC. | $66.47 | 2020 | |
| Radius Health, INC. | $64.93 | 2019-2020 | |
| Kairos Surgical INC | $54.83 | 2019 | |
| Collegium Pharmaceutical, INC. | $50.81 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.66 | 2019 | |
| Bioventus LLC | $31.90 | 2019 | |
| Kaleo, INC. | $29.60 | 2019 | |
| Shionogi INC | $28.44 | 2019 | |
| Allergan, INC. | $27.48 | 2019-2020 | |
| Fidia Pharma USA INC. | $19.90 | 2019 | |
| Stryker Corporation | $19.34 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.88 | 2019 | |
| Piramal Critical Care | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Greenspan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.